Vibe Coding Moves Beyond the Proteomics Prototype

• by James Strachan

• September 30, 2026

Rethinking Infection Diagnostics in Cystic Fibrosis

A dedicated syndicate is connecting academia, industry, and people with cystic fibrosis to advance diagnostic research

• by Mollie Spindler

• September 17, 2026

• 6 min

FDA clears targeted cholangiocarcinoma therapy

In the single-arm REFOCUS trial, 46% of patients responded to treatment, with a median response duration of 11.8 months.

• by Kathryn Wighton

• September 24, 2026

• 2 min

Hot drink habits and esophageal cancer

Researchers assessed preferred hot drink temperature and consumption frequency across 2 large UK cohorts.

• by Kathryn Wighton

• September 16, 2026

• 4 min